ImmuCell Corporation (ICCC) Dividend Safety
- Dividend payout ratio · 12 months: Value (m); Formula and calculation Cash dividends paid / net income. Period ending 2026-06-30..
Dividend safety
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Dividend payout ratio · 12 months | (m) | Cash dividends paid / net income. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Dividend payments · 12 months | (m) | |
| Net income · 12 months | 787.40K USD | Net Income (Loss) Attributable to Parent |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Dividend payments · 12 months (USD) | Net income · 12 months (USD) | Dividend payout |
|---|---|---|---|
| 2026-06-30 | (m) | $787.40K | (m) |
| 2026-03-31 | (m) | $-545.38K | (m) |
| 2025-12-31 | (m) | $-1.04M | (m) |
| 2025-09-30 | (m) | $2.32M | (m) |
| 2025-06-30 | (m) | $1.76M | (m) |
| 2025-03-31 | (m) | $-271.78K | (m) |
| 2024-12-31 | (m) | $-2.16M | (m) |
| 2024-09-30 | (m) | $-3.81M | (m) |
| 2024-06-30 | (m) | $-4.05M | (m) |
| 2024-03-31 | (m) | $-3.90M | (m) |
| 2023-12-31 | (m) | $-5.77M | (m) |
| 2023-09-30 | (m) | $-6.30M | (m) |
| 2023-06-30 | (m) | $-6.02M | (m) |
| 2023-03-31 | (m) | $-5.32M | (m) |
| 2022-12-31 | (m) | $-2.49M | (m) |
| 2022-09-30 | (m) | $-751.80K | (m) |
| 2022-06-30 | (m) | $273.42K | (m) |
| 2022-03-31 | (m) | $1.10M | (m) |
| 2021-12-31 | (m) | $-78.29K | (m) |
| 2021-09-30 | (m) | $36.40K | (m) |
| 2021-06-30 | (m) | $-434.25K | (m) |
| 2021-03-31 | (m) | $-1.34M | (m) |
| 2020-12-31 | (m) | $-1.02M | (m) |
| 2020-09-30 | (m) | $-1.52M | (m) |
| 2020-06-30 | (m) | $-1.70M | (m) |
| 2020-03-31 | (m) | $-1.56M | (m) |
| 2019-12-31 | (m) | $-1.30M | (m) |
| 2019-09-30 | (m) | $-2.04M | (m) |
| 2019-06-30 | (m) | $-1.78M | (m) |
| 2019-03-31 | (m) | $-1.96M | (m) |
| 2018-12-31 | (m) | $-2.32M | (m) |
| 2018-09-30 | (m) | $-1.46M | (m) |
| 2018-06-30 | (m) | $-1.55M | (m) |
| 2018-03-31 | (m) | $-973.51K | (m) |
| 2017-12-31 | (m) | $-168.15K | (m) |
| 2017-09-30 | (m) | $56.79K | (m) |
| 2017-06-30 | (m) | $431.01K | (m) |
| 2017-03-31 | (m) | $640.24K | (m) |
| 2016-12-31 | (m) | $508.45K | (m) |
| 2016-09-30 | (m) | $766.97K | (m) |
| 2016-06-30 | (m) | $1.08M | (m) |
| 2016-03-31 | (m) | $1.19M | (m) |
| 2015-12-31 | (m) | $1.21M | (m) |
| 2015-09-30 | (m) | $1.06M | (m) |
| 2015-06-30 | (m) | $714.10K | (m) |
| 2015-03-31 | (m) | $325.26K | (m) |
| 2014-12-31 | (m) | $-167.16K | (m) |
| 2014-09-30 | (m) | $-448.49K | (m) |
| 2014-06-30 | (m) | $-401.48K | (m) |
| 2014-03-31 | (m) | $-100.25K | (m) |
| 2013-12-31 | (m) | $117.39K | (m) |
| 2013-09-30 | (m) | $251.24K | (m) |
| 2013-06-30 | (m) | $130.32K | (m) |
| 2013-03-31 | (m) | $139.06K | (m) |
| 2012-12-31 | (m) | $89.51K | (m) |
| 2012-09-30 | (m) | $105.84K | (m) |
| 2012-06-30 | (m) | $41.77K | (m) |
| 2012-03-31 | (m) | $-231.64K | (m) |
| 2011-12-31 | (m) | $-409.51K | (m) |
| 2011-09-30 | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) |
| 2010-12-31 | (m) | $-384.68K | (m) |
| 2010-09-30 | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) |
| 2009-12-31 | (m) | $-216.49K | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |